88 related articles for article (PubMed ID: 21310580)
1. Examining risk perception among men with a family history of prostate cancer.
Matthew AG; Paradiso C; Currie KL; Finelli A; Hartman ME; Trachtenberg L; Shuman C; Horsburgh S; Chitayat D; Trachtenberg J; Ritvo P
Patient Educ Couns; 2011 Nov; 85(2):251-7. PubMed ID: 21310580
[TBL] [Abstract][Full Text] [Related]
2. Relation of family history of prostate cancer to perceived vulnerability and screening behavior.
Jacobsen PB; Lamonde LA; Honour M; Kash K; Hudson PB; Pow-Sang J
Psychooncology; 2004 Feb; 13(2):80-5. PubMed ID: 14872526
[TBL] [Abstract][Full Text] [Related]
3. A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Baade PD; Steginga SK
Eur J Cancer Care (Engl); 2009 Nov; 18(6):545-55. PubMed ID: 19686273
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of cancer specific distress in men with a family history of prostate cancer.
McDowell ME; Occhipinti S; Gardiner RA; Chambers SK
Psychooncology; 2013 Nov; 22(11):2496-504. PubMed ID: 23712946
[TBL] [Abstract][Full Text] [Related]
5. The relationship between prostate cancer knowledge and beliefs and intentions to attend PSA screening among at-risk men.
Hevey D; Pertl M; Thomas K; Maher L; Chuinneagáin SN; Craig A
Patient Educ Couns; 2009 Feb; 74(2):244-9. PubMed ID: 18848753
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer screening in men with a family history of prostate cancer: the role of partners in influencing men's screening uptake.
Meiser B; Cowan R; Costello A; Giles GG; Lindeman GJ; Gaff CL
Urology; 2007 Oct; 70(4):738-42. PubMed ID: 17991547
[TBL] [Abstract][Full Text] [Related]
7. Psychological aspects of screening in families with hereditary prostate cancer.
Bratt O; Emanuelsson M; Grönberg H
Scand J Urol Nephrol; 2003; 37(1):5-9. PubMed ID: 12745735
[TBL] [Abstract][Full Text] [Related]
8. Adherence to an annual PSA screening program over 3 years for brothers and sons of men with prostate cancer.
Roumier X; Azzouzi R; Valéri A; Guillemin F; Fournier G; Cussenot O; Mangin P; Cormier L
Eur Urol; 2004 Mar; 45(3):280-5; author reply 285-6. PubMed ID: 15036671
[TBL] [Abstract][Full Text] [Related]
9. The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
Watson M; Lloyd S; Davidson J; Meyer L; Eeles R; Ebbs S; Murday V
Br J Cancer; 1999 Feb; 79(5-6):868-74. PubMed ID: 10070883
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening trends of New York State men at least 50 years of age, 1994 to 1997.
McDavid K; Melnik TA; Derderian H
Prev Med; 2000 Sep; 31(3):195-202. PubMed ID: 10964632
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with perceived risk in automotive employees at increased risk of colorectal cancer.
Vernon SW; Myers RE; Tilley BC; Li S
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):35-43. PubMed ID: 11205487
[TBL] [Abstract][Full Text] [Related]
12. Risk perception and concern among brothers of men with prostate carcinoma.
Beebe-Dimmer JL; Wood DP; Gruber SB; Chilson DM; Zuhlke KA; Claeys GB; Cooney KA
Cancer; 2004 Apr; 100(7):1537-44. PubMed ID: 15042690
[TBL] [Abstract][Full Text] [Related]
13. Cancer worry is associated with abnormal prostate-specific antigen levels in men participating in a community screening program.
Cohen L; Fouladi RT; Babaian RJ; Bhadkamkar VA; Parker PA; Taylor CC; Smith MA; Gritz ER; Basen-Engquist K
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):610-7. PubMed ID: 12869399
[TBL] [Abstract][Full Text] [Related]
14. Do the risk factors of age, family history of prostate cancer or a higher prostate specific antigen level raise anxiety at prostate biopsy?
Macefield RC; Lane JA; Metcalfe C; Down L; Neal DE; Hamdy FC; Donovan JL
Eur J Cancer; 2009 Sep; 45(14):2569-73. PubMed ID: 19375907
[TBL] [Abstract][Full Text] [Related]
15. Does enhanced information at cancer genetic counseling improve counselees' knowledge, risk perception, satisfaction and negotiation of information to at-risk relatives?--a randomized study.
Roshanai AH; Rosenquist R; Lampic C; Nordin K
Acta Oncol; 2009; 48(7):999-1009. PubMed ID: 19636983
[TBL] [Abstract][Full Text] [Related]
16. Family history of cancer and utilization of prostate, colorectal and skin cancer screening tests in U.S. men.
Shah M; Zhu K; Palmer RC; Wu H
Prev Med; 2007 May; 44(5):459-64. PubMed ID: 17320159
[TBL] [Abstract][Full Text] [Related]
17. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
O'Dell KJ; Volk RJ; Cass AR; Spann SJ
J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
[TBL] [Abstract][Full Text] [Related]
18. Measuring the psychosocial impact of population-based prostate-specific antigen testing for prostate cancer in the UK.
Brindle LA; Oliver SE; Dedman D; Donovan JL; Neal DE; Hamdy FC; Lane JA; Peters TJ
BJU Int; 2006 Oct; 98(4):777-82. PubMed ID: 16978272
[TBL] [Abstract][Full Text] [Related]
19. Age at diagnosis and age at death in familial prostate cancer.
Brandt A; Bermejo JL; Sundquist J; Hemminki K
Oncologist; 2009 Dec; 14(12):1209-17. PubMed ID: 19939895
[TBL] [Abstract][Full Text] [Related]
20. Hereditary aspects of prostate cancer.
McLellan DL; Norman RW
CMAJ; 1995 Oct; 153(7):895-900. PubMed ID: 7553490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
